Polycythemia: all 184 studies
Page 2 of 2. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.
- An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to RuxolitinibStatus unknownNCT04485260Phase 1/2
- The TAPS Trial - Fetoscopic Laser Surgery for Twin Anemia Polycythemia SequenceStatus unknownNCT04432168Not applicable
- Study of Select Combinations in Adults With MyelofibrosisWithdrawnNCT04283526Phase 1
- Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm PatientsCompletedNCT04243122Phase 2
- Jaktinib for the Treatment of Ruxolitinib Intolerance of MyelofibrosisCompletedNCT04217993Phase 2
- PAT-1251 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis MyelofibrosisWithdrawnNCT04054245Phase 2
- Dual Vaccine Trial in Myeloproliferative NeoplasmsCompletedNCT04051307Phase 1/2
- CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential ThrombocythemiaTerminatedNCT03972943Early Phase 1
- Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking RuxolitinibTerminatedNCT03935555Phase 1
- The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility PhaseCompletedNCT03907436Not applicable
- MPN-RC 118 AVID200 in MyelofibrosisCompletedNCT03895112Phase 1
- Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)CompletedNCT03745378
- KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia VeraStatus unknownNCT03669965Phase 2
- Influence of Umbilical Cord Clamping Time in the NewbornCompletedNCT03624335Not applicable
- Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of MyelofibrosisTerminatedNCT03373877Phase 1
- Genomic Screening for Hereditary Erythrocytosis and Related DiseasesStatus unknownNCT03263364
- 18F-FLT (PET/CT) in Pediatrics With Myeloproliferative NeoplasmsTerminatedNCT03121599Not applicable
- CO-Rebreathing in Comparison to Isotopic Red Cell Volume Determination in the Diagnosis of Primitive and Secondary PolycythemiaCompletedNCT03008642Not applicable
- The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PVCompletedNCT03003325Phase 2
- Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot StructureCompletedNCT02912884
- Drug Observance and Side Effects of Cytoreductive Drugs in PV and ET PatientsCompletedNCT02893410
- Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia MyelofibrosisWithdrawnNCT02871323Phase 1
- Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative NeoplasmsCompletedNCT02823184
- Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease FeaturesStatus unknownNCT02809274
- Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia MyelofibrosisWithdrawnNCT02805868Early Phase 1
- Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative DisordersWithdrawnNCT02663648
- H-36731: Finasteride in Management of Elevated Red Blood CellsWithdrawnNCT02548117Phase 3
- Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera PatientsCompletedNCT02523638Phase 3
- Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential ThrombocythemiaCompletedNCT02407080Phase 1
- Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutationCompletedNCT02311569Phase 2
- Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)CompletedNCT02252159
- AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.CompletedNCT02218047Phase 3
- Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid MalignanciesCompletedNCT02129101Phase 1
- Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential ThrombocythemiaTerminatedNCT01998828Phase 2
- Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) PatientsCompletedNCT01970930
- Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia VeraCompletedNCT01949805Phase 3
- An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic DiseaseStatus unknownNCT01846689Phase 3
- Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative NeoplasmsCompletedNCT01816256Not applicable
- Myeloproliferative Neoplasms and Bone StructureStatus unknownNCT01816022
- Ruxolitinib for Chuvash PolycythemiaNo longer availableNCT01730755
- Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With SplenomegalyCompletedNCT01692366Phase 2
- Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV)TerminatedNCT01645124Phase 3
- Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell TransplantCompletedNCT01588015Phase 1
- Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative NeoplasmsCompletedNCT01520220Phase 1
- Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosisCompletedNCT01433445Phase 1
- Safety Study Evaluating Twice-Daily Administration of Momelotinib in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia MyelofibrosisCompletedNCT01423058Phase 1/2
- Study With SAR302503 in Patients With Polycythemia Vera or Essential ThrombocythemiaCompletedNCT01420783Phase 2
- Study of the Effects of Commercial Air Travel on the LungsCompletedNCT01420224
- A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid NeoplasmsCompletedNCT01387763Phase 3
- LBH589 (Panobinostat) for the Treatment of MyelofibrosisStatus unknownNCT01298934Phase 1/2
- Natural Killer Cells and Polycythemia Vera (Vaquez's Disease)Status unknownNCT01284712
- Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)CompletedNCT01259817Phase 2
- Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia VeraCompletedNCT01243073Phase 2
- Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)CompletedNCT01236638Phase 2
- Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia VeraCompletedNCT01193699Phase 1/2
- Study of Cobalt's Role in Excessive Erythrocytosis Among High Altitude Dwellers in Cerro de Pasco, PeruCompletedNCT01187108Phase 1/2
- A Study in Myeloproliferative DisordersCompletedNCT01134120Phase 1
- Treatment of Polycythemia Vera With GleevecCompletedNCT01120821Phase 2
- Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for CancerCompletedNCT01053494Not applicable
- Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With MyelofibrosisTerminatedNCT01014546Phase 1
- Clopidogrel and Aspirin for the Treatment of Polycythemia VeraWithdrawnNCT00940784Phase 2
- Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)CompletedNCT00935987Phase 1/2
- Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
- A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential ThrombocythaemiaStatus unknownNCT00866762Phase 2
- A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic MalignanciesCompletedNCT00807677Phase 1
- A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic MyelofibrosisCompletedNCT00745550Phase 1/2
- Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET GenesCompletedNCT00715247
- CEP-701 (Lestaurtinib) in MyelofibrosisStatus unknownNCT00668421Phase 1/2
- Research Tissue BankCompletedNCT00666549
- Familial Myeloproliferative DisordersCompletedNCT00666289
- Correlative Biomarker Study in Patients With Myeloproliferative DisordersCompletedNCT00665067
- A Phase 1 Study of XL019 in Adults With Polycythemia VeraTerminatedNCT00595829Phase 1
- Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative DisordersCompletedNCT00588991Phase 1
- A Safety Study of XL019 in Adults With MyelofibrosisTerminatedNCT00522574Phase 1
- Pulmonary Hypertension, Hypoxia and Sickle Cell DiseaseCompletedNCT00495638
- Molecular Changes and Biomarkers in Chronic Myeloproliferative DisordersCompletedNCT00433862
- Effects of Imatinib Mesylate in Polycythemia VeraCompletedNCT00430066Phase 2
- Treatment of High Altitude Polycythemia by AcetazolamideCompletedNCT00424970Phase 4
- Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative DisordersCompletedNCT00357305Phase 1
- Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia VeraCompletedNCT00241241Phase 2
- Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell TransplantationCompletedNCT00052520Phase 1/2
- Tipifarnib in Treating Patients With Myelofibrosis and Myeloid MetaplasiaCompletedNCT00047190Phase 2
- Imatinib Mesylate in Treating Patients With MyelofibrosisCompletedNCT00039416Phase 2
- Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNCT00025415Phase 1